Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

The Relationship Between Acute Malnutrition, Hygiene Practices, Water and Livestock, and Their Program Implications in Eastern Chad.

Marshak A, Young H, Bontrager EN, Boyd EM.

Food Nutr Bull. 2016 Dec 8. pii: 0379572116681682. [Epub ahead of print]

PMID:
27932595
2.

Biomimetic synthesis of dendridine A.

Boyd EM, Sperry J.

Org Lett. 2015 Mar 6;17(5):1344-6. doi: 10.1021/acs.orglett.5b00300. Epub 2015 Feb 20.

PMID:
25699647
3.

Total synthesis of (-)-aspergilazine A.

Boyd EM, Sperry J.

Org Lett. 2014 Oct 3;16(19):5056-9. doi: 10.1021/ol5024097. Epub 2014 Sep 23.

PMID:
25248025
4.

High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies.

Boyd EM, Bench AJ, van 't Veer MB, Wright P, Bloxham DM, Follows GA, Scott MA.

Br J Haematol. 2011 Dec;155(5):609-12. doi: 10.1111/j.1365-2141.2011.08868.x. Epub 2011 Sep 13.

PMID:
21910720
5.

Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis.

Boyd EM, Bench AJ, Goday-Fernández A, Anand S, Vaghela KJ, Beer P, Scott MA, Bareford D, Green AR, Huntly B, Erber WN.

Br J Haematol. 2010 Apr;149(2):250-7. doi: 10.1111/j.1365-2141.2010.08083.x. Epub 2010 Feb 11.

PMID:
20151976
6.

Frequency tunable near-infrared metamaterials based on VO2 phase transition.

Dicken MJ, Aydin K, Pryce IM, Sweatlock LA, Boyd EM, Walavalkar S, Ma J, Atwater HA.

Opt Express. 2009 Sep 28;17(20):18330-9. doi: 10.1364/OE.17.018330.

PMID:
19907624
7.

Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms.

Grimwade LF, Happerfield L, Tristram C, McIntosh G, Rees M, Bench AJ, Boyd EM, Hall M, Quinn A, Piggott N, Scorer P, Scott MA, Erber WN.

Br J Haematol. 2009 Nov;147(4):495-506. doi: 10.1111/j.1365-2141.2009.07870.x. Epub 2009 Aug 31.

PMID:
19747364
8.

Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones.

Beer PA, Jones AV, Bench AJ, Goday-Fernandez A, Boyd EM, Vaghela KJ, Erber WN, Odeh B, Wright C, McMullin MF, Cullis J, Huntly BJ, Harrison CN, Cross NC, Green AR.

Br J Haematol. 2009 Mar;144(6):904-8. doi: 10.1111/j.1365-2141.2008.07560.x. Epub 2009 Jan 16.

PMID:
19170680
9.

Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes.

Boyd EM, Bench AJ, Vaghela KJ, Campbell GN, Chowdhury FB, Gudgin EJ, Scott MA, Erber WN.

Leukemia. 2009 Jun;23(6):1164-7. doi: 10.1038/leu.2008.383. Epub 2009 Jan 22. No abstract available.

PMID:
19158836
10.

Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders.

Fourouclas N, Li J, Gilby DC, Campbell PJ, Beer PA, Boyd EM, Goodeve AC, Bareford D, Harrison CN, Reilly JT, Green AR, Bench AJ.

Haematologica. 2008 Nov;93(11):1635-44. doi: 10.3324/haematol.13043. Epub 2008 Sep 24.

11.

Emotion work in the public performances of male-to-female transsexuals.

Schrock DP, Boyd EM, Leaf M.

Arch Sex Behav. 2009 Oct;38(5):702-12. Epub 2007 Nov 29.

PMID:
18046637
12.

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

Campbell PJ, Scott LM, Buck G, Wheatley K, East CL, Marsden JT, Duffy A, Boyd EM, Bench AJ, Scott MA, Vassiliou GS, Milligan DW, Smith SR, Erber WN, Bareford D, Wilkins BS, Reilly JT, Harrison CN, Green AR; United Kingdom Myeloproliferative Disorders Study Group; Medical Research Council Adult Leukaemia Working Party; Australasian Leukaemia and Lymphoma Group.

Lancet. 2005 Dec 3;366(9501):1945-53.

PMID:
16325696
13.

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR; Cancer Genome Project.

Lancet. 2005 Mar 19-25;365(9464):1054-61. Erratum in: Lancet. 2005 Jul 9-15;366(9480):122.

PMID:
15781101
14.
15.

Quantitative structure-toxicity relationships for chlorophenols to bioluminescent lux-marked bacteria using atom-based semi-empirical molecular-orbital descriptors.

Warne MA, Boyd EM, Meharg AA, Osborn D, Killham K, Lindon JC, Nicholson JK.

SAR QSAR Environ Res. 1999;10(5):473-95.

PMID:
10649840
16.

Squamous cell carcinoma arising in the epithelial lining of a dentigerous cyst.

Roofe SB, Boyd EM Jr, Houston GD, Edgin WA.

South Med J. 1999 Jun;92(6):611-4.

PMID:
10372856
17.

Benefits of stereolithography in orbital reconstruction.

Holck DE, Boyd EM Jr, Ng J, Mauffray RO.

Ophthalmology. 1999 Jun;106(6):1214-8.

PMID:
10366095
18.

Long-term follow-up of aviators after functional endoscopic sinus surgery for sinus barotrauma.

Parsons DS, Chambers DW, Boyd EM.

Aviat Space Environ Med. 1997 Nov;68(11):1029-34.

PMID:
9383504
19.

Toxicity assessment of xenobiotic contaminated groundwater using lux modified Pseudomonas fluorescens.

Boyd EM, Killham K, Wright J, Rumford S, Hetheridge M, Cumming R, Meharg AA.

Chemosphere. 1997 Nov;35(9):1967-85.

PMID:
9353912
20.

Rehabilitation of lower cranial nerve deficits.

Eibling DE, Boyd EM.

Otolaryngol Clin North Am. 1997 Oct;30(5):865-75. Review.

PMID:
9295257
21.

Pediatric sphenoidotomy.

Smith WC, Boyd EM, Parsons DS.

Otolaryngol Clin North Am. 1996 Feb;29(1):159-67.

PMID:
8834279
22.

Facial paralysis and inflammatory pseudotumor of the facial nerve in a child.

Wiseman JB, Arriaga MA, Houston GD, Boyd EM.

Otolaryngol Head Neck Surg. 1995 Dec;113(6):826-8. No abstract available.

PMID:
7501405
23.

Post-tubal-sterilization syndrome.

Boyd EM.

J R Coll Gen Pract. 1987 Jun;37(299):272. No abstract available.

24.

Clonidine for opiate withdrawal.

Boyd EM.

Am Fam Physician. 1986 Jun;33(6):42, 47. No abstract available. Erratum in: Am Fam Physician 1986 Aug;34(2):24.

PMID:
3716972
25.

Contract learning.

Boyd EM.

Phys Ther. 1979 Mar;59(3):278-81.

PMID:
419171
26.

Studies on respiratory tract fluid.

Boyd EM.

Arzneimittelforschung. 1972 Mar;22(3):612-6. No abstract available.

PMID:
5067943
27.

The influence of diets containing from 0 to 81 per cent of protein on tolerated doses of pesticides.

Krijnen CJ, Boyd EM.

Comp Gen Pharmacol. 1971 Dec;2(8):373-6. No abstract available.

PMID:
4125710
28.

Intolerance to cottonseed oil in rats fed a low protein diet.

Boyd EM, Krijnen CJ.

Food Cosmet Toxicol. 1971 Jun;9(3):389-94. No abstract available.

PMID:
5109186
29.

100-day LD 50 index of chronic toxicity.

Boyd EM.

Clin Toxicol. 1971 Jun;4(2):205-13. No abstract available.

PMID:
5097490
30.

Effect of caffeine and phenacetin on thiopental-induced hypothermia and anesthesia.

Singh JM, Boyd EM.

Clin Toxicol. 1971 Jun;4(2):173-83. No abstract available.

PMID:
5097489
31.

The safety and toxicity of aspirin.

Boyd EM.

Am J Nurs. 1971 May;71(5):964-6. No abstract available.

PMID:
5205653
32.

Sterility from phenacetin.

Boyd EM.

J Clin Pharmacol New Drugs. 1971 Mar-Apr;11(2):96-102. No abstract available.

PMID:
5206474
33.

An autumn-enhanced mucotropic action of inhaled terpenes and related volatile agents.

Boyd EM, Sheppard EP.

Pharmacology. 1971;6(2):65-80. No abstract available.

PMID:
5138742
34.

The 100-day LD50 index of captan.

Boyd EM, Carsky E.

Acta Pharmacol Toxicol (Copenh). 1971;29(23):226-40. No abstract available.

PMID:
5108606
35.

Toxaphene toxicity in protein-deficient rats.

Boyd EM, Taylor FI.

Toxicol Appl Pharmacol. 1971 Jan;18(1):158-67. No abstract available.

PMID:
5100790
36.

Encephalopathy in toxicity tests on laboratory animals.

Boyd EM.

Arch Toxikol. 1971;27(2):85-98. Review. No abstract available.

PMID:
4931383
37.

The effect of inhalation of citral and geraniol on the output and composition of respiratory tract fluid.

Boyd EM, Sheppard EP.

Arch Int Pharmacodyn Ther. 1970 Nov;188(1):5-13. No abstract available.

PMID:
5485103
38.

Protein-deficient diet and diuron toxicity.

Boyd EM, Krupa V.

J Agric Food Chem. 1970 Nov-Dec;18(6):1104-7. No abstract available.

PMID:
5483048
39.

Nutmeg oil and camphene as inhaled expectorants.

Procter DF, Boyd EM.

Arch Otolaryngol. 1970 Oct;92(4):411-2. No abstract available.

PMID:
5455589
40.

Nutmeg oil and camphene as inhaled expectorants.

Boyd EM, Sheppard P.

Arch Otolaryngol. 1970 Oct;92(4):372-8. No abstract available.

PMID:
5455578
41.

Clinical and pathological parameters in albino rats fed from weaning on a diet containing no protein.

Boyd EM.

Can J Physiol Pharmacol. 1970 Aug;48(8):524-32. No abstract available.

PMID:
5465938
42.

Acute oral toxicity of dimethoate in albino rats fed a protein-deficient diet.

Boyd EM, Muis LF.

J Pharm Sci. 1970 Aug;59(8):1098-102. No abstract available.

PMID:
5457324
43.

Endosulfan toxicity and dietary protein.

Boyd EM, Dobos I, Krijnen CJ.

Arch Environ Health. 1970 Jul;21(1):15-9. No abstract available.

PMID:
5422318
44.

Testicular atrophy from analgesic drugs.

Boyd EM.

J Clin Pharmacol J New Drugs. 1970 Jul-Aug;10(4):222-7. No abstract available.

PMID:
5269365
45.

A review of phenacetin toxicity in animals.

Boyd EM.

Appl Ther. 1970 Jul;12(7):9-15. Review. No abstract available.

PMID:
4920538
47.

Toxicity of dicophane (DDT) in relation to dietary protein intake.

Boyd EM, De Castro ES.

IMS Ind Med Surg. 1970 May;39(5):229-36. No abstract available.

PMID:
5266611
48.

Resistance to starvation in albino rats fed from weaning on diets containing from 0 to 81 per cent of protein as casein.

Boyd EM, Chen CP, Muis LF.

Growth. 1970 Mar;34(1):99-112. No abstract available.

PMID:
5430072
49.

Susceptibility to captan pesticide of albino rats fed from weaning on diets containing various levels of protein.

Krijnen CJ, Boyd EM.

Food Cosmet Toxicol. 1970 Feb;8(1):35-42. No abstract available.

PMID:
4190966
50.

Maximal tolerated daily doses of dicophane.

Boyd EM, Lin FM.

Acta Pharmacol Toxicol (Copenh). 1970;28(2):149-60. No abstract available.

PMID:
5468403

Supplemental Content

Support Center